121 related articles for article (PubMed ID: 9645444)
1. Expression of bcl-2 oncoprotein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Tominaga S; Kawai T; Torikata C; Aurues T; Ikeda T
Virchows Arch; 1998 May; 432(5):445-50. PubMed ID: 9645444
[TBL] [Abstract][Full Text] [Related]
2. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of p53 oncoprotein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Torikata C
Hum Pathol; 1996 Dec; 27(12):1336-40. PubMed ID: 8958308
[TBL] [Abstract][Full Text] [Related]
4. Growth factors and oncogene products in transitional cell carcinoma.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230
[TBL] [Abstract][Full Text] [Related]
5. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin expression in upper-urinary-tract carcinoma.
Nakanishi K; Kawai T; Torikata C; Aurues T; Ikeda T
Int J Cancer; 1997 Aug; 74(4):446-9. PubMed ID: 9291437
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter.
Kamijima S; Tobe T; Suyama T; Ueda T; Igarashi T; Ichikawa T; Ito H
Int J Urol; 2005 Nov; 12(11):941-7. PubMed ID: 16351648
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder.
Li B; Kanamaru H; Noriki S; Yamaguchi T; Fukuda M; Okada K
Urol Res; 1998; 26(4):235-41. PubMed ID: 9759996
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
[TBL] [Abstract][Full Text] [Related]
12. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
14. Expression of telomerase mRNA component (hTR) in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Hiroi S; Kumaki F; Torikata C; Aurues T; Ikeda T
Cancer; 1999 Nov; 86(10):2109-16. PubMed ID: 10570439
[TBL] [Abstract][Full Text] [Related]
15. Expression of telomerase catalytic subunit (hTERT) mRNA does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
Mod Pathol; 2001 Nov; 14(11):1073-8. PubMed ID: 11706066
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of p53, MDM2 and bcl-2 expression in transitional cell carcinoma of the bladder.
Uchida T; Minei S; Gao JP; Wang C; Satoh T; Baba S
Oncol Rep; 2002; 9(2):253-9. PubMed ID: 11836589
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.
Ong F; Moonen LM; Gallee MP; ten Bosch C; Zerp SF; Hart AA; Bartelink H; Verheij M
Radiother Oncol; 2001 Nov; 61(2):169-75. PubMed ID: 11690683
[TBL] [Abstract][Full Text] [Related]
18. Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter.
Hashimoto H; Sue Y; Saga Y; Tokumitsu M; Yachiku S
Int J Urol; 2000 Dec; 7(12):457-63. PubMed ID: 11168685
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
[TBL] [Abstract][Full Text] [Related]
20. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
